Today, a story about advances in treating the most deadly form of cancer: lung cancer. Those diagnosed will more than likely die within a year. Andy Bonnett, of Denver, was in his early 30's when he was told he had the disease. "I was actually quite shocked, and confused, and incredibly sad to hear those words," he said. That was two and a half years ago. Bonnett got very sick and progressed to the most advanced stage of the disease. But now, he's better, thanks to an experimental drug he's taking through the University of Colorado Cancer Center. It's called Crizotinib. And just 100 people on the planet are taking it. Thirty-five of them are doing so here in Colorado. For Andy Bonnett, and many others, the results have been extraordinary. Andy's with us along with Dr. Ross Camidge, the clinical director of UC-Denver's Lung Cancer program.
Promising New Cancer Drug at UC-Denver
By Zachary Barr Jun 11, 2010
Award-Winning Journalism From The Colorado Public Radio Newsroom
Explore the growing list of CPR's award-winning stories.
A Look At The Data: Colorado's Economy In Charts
You'll be hearing a lot of claims this election season, so we're collecting Colorado economic data that will help you get right to the facts.
Most Viewed News
By Ryan Warner
By Ben Markus